[S02DA03, antipyrine, The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Neomycin.]
[J01GA01, streptomycin, The risk or severity of nephrotoxicity can be increased when Streptomycin is combined with Neomycin.]
[M03AB01, succinylcholine, The therapeutic efficacy of Succinylcholine can be increased when used in combination with Neomycin.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CG01, sulbactam, Sulbactam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CA16, sulbenicillin, The serum concentration of Neomycin can be decreased when it is combined with Sulbenicillin.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Sulfamethoxazole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AB02, sulindac, The risk or severity of nephrotoxicity can be increased when Sulindac is combined with Neomycin.]
[N05AL01, sulpiride, Sulpiride may increase the neurotoxic activities of Neomycin.]
[M01AX04, apazone, The risk or severity of nephrotoxicity can be increased when Azapropazone is combined with Neomycin.]
[J01CA15, talampicillin, The serum concentration of Neomycin can be decreased when it is combined with Talampicillin.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01CB02, teniposide, Teniposide may increase the neurotoxic activities of Neomycin.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Dabigatran etexilate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Tetracaine.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, The risk or severity of nephrotoxicity can be increased when Ceftaroline fosamil is combined with Neomycin.]
[N05AE05, lurasidone, Neomycin may increase the neurotoxic activities of Lurasidone.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AB08, thioproperazine, Neomycin may increase the neurotoxic activities of Thioproperazine.]
[N05AC02, thioridazine, Thioridazine may increase the neurotoxic activities of Neomycin.]
[N05AF04, thiothixene, Neomycin may increase the neurotoxic activities of Thiothixene.]
[G04BE06, moxisylyte, Moxisylyte may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AL03, tiapride, Tiapride may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CA13, ticarcillin, The serum concentration of Neomycin can be decreased when it is combined with Ticarcillin.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01ED01, timolol, Timolol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01AA12, tobramycin, The risk or severity of nephrotoxicity can be increased when Tobramycin is combined with Neomycin.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V04CA01, tolbutamide, Tolbutamide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M02AA21, tolmetin, The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Neomycin.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C03DB02, triamterene, The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Neomycin.]
[N05CD05, triazolam, Triazolam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A16AX12, trientine, Triethylenetetramine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AB06, trifluoperazine, Trifluoperazine may increase the neurotoxic activities of Neomycin.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AD02, trifluperidol, Neomycin may increase the neurotoxic activities of Trifluperidol.]
[N05AA05, triflupromazine, Triflupromazine may increase the neurotoxic activities of Neomycin.]
[A03AA05, trimebutine, Trimebutine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[R06AD01, trimeprazine, Neomycin may increase the neurotoxic activities of Alimemazine.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Neomycin is combined with Trimethaphan.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AA06, trimipramine, Trimipramine may increase the neurotoxic activities of Neomycin.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be increased when used in combination with Neomycin.]
[R03DX07, roflumilast, Roflumilast may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01FX04, ipilimumab, Ipilimumab may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[R02AA14, oxyquinoline, Oxyquinoline may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01AA28, vancomycin, The risk or severity of nephrotoxicity can be increased when Vancomycin is combined with Neomycin.]
[N03AX21, ezogabine, Ezogabine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AF01, rivaroxaban, Rivaroxaban may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C08DA01, verapamil, Verapamil may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AX09, viloxazine, Viloxazine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01CA02, vincristine, Vincristine may increase the neurotoxic activities of Neomycin.]
[B03BA01, vitamin B12, Neomycin can cause a decrease in the absorption of Cyanocobalamin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B01AA03, warfarin, Neomycin may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[N05AF05, zuclopenthixol, Neomycin may increase the neurotoxic activities of Zuclopenthixol.]
[M05BA03, pamidronic acid, The risk or severity of nephrotoxicity can be increased when Pamidronic acid is combined with Neomycin.]
[M05BA05, tiludronic acid, Tiludronic acid may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B06AC02, icatibant, Icatibant may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Neomycin is combined with Ibandronate.]
[N05AE04, ziprasidone, Ziprasidone may increase the neurotoxic activities of Neomycin.]
[V03AC02, deferiprone, Deferiprone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N02BA01, aspirin, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Neomycin.]
[L01EJ01, ruxolitinib, Ruxolitinib may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G04BD07, tolterodine, Tolterodine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01DH04, doripenem, Doripenem may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M03AC04, atracurium, The therapeutic efficacy of Atracurium can be increased when used in combination with Neomycin.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B03XA04, peginesatide, Peginesatide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L04AX01, azathioprine, Azathioprine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CA09, azlocillin, The serum concentration of Neomycin can be decreased when it is combined with Azlocillin.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M03BX01, baclofen, Neomycin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A08AA11, lorcaserin, Lorcaserin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G04BD12, mirabegron, Mirabegron may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L02BB04, enzalutamide, Enzalutamide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A02AA05, magnesium silicate, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Magnesium silicate.]
[C01AA01, acetyldigitoxin, The risk or severity of adverse effects can be increased when Neomycin is combined with Acetyldigitoxin.]
[D02BA02, octinoxate, Octinoxate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N04BD02, rasagiline, Rasagiline may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V09IX04, fluorodeoxyglucose F18, Fludeoxyglucose (18F) may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AA01, ethyl ether, Neomycin may increase the neurotoxic activities of Diethyl ether.]
[V08CA11, gadofosveset, Gadofosveset trisodium may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A16AX08, teduglutide, Teduglutide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A10BH04, alogliptin, Alogliptin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Glycerol phenylbutyrate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L04AX06, pomalidomide, Pomalidomide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N02BA10, benorilate, The risk or severity of nephrotoxicity can be increased when Benorilate is combined with Neomycin.]
[N05AD07, benperidol, Neomycin may increase the neurotoxic activities of Benperidol.]
[A10BK02, canagliflozin, Canagliflozin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A12CC09, magnesium orotate, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Magnesium orotate.]
[L03AA12, ancestim, Ancestim may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AH01, celecoxib, The risk or severity of nephrotoxicity can be increased when Celecoxib is combined with Neomycin.]
[A12CC05, magnesium aspartate, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Magnesium aspartate.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[R02AX03, benzydamine, The risk or severity of nephrotoxicity can be increased when Benzydamine is combined with Neomycin.]
[L01EE01, trametinib, Trametinib may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Benzyl alcohol.]
[V09AX05, florbetapir F-18, Florbetapir (18F) may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AX28, levomilnacipran, Levomilnacipran may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A10BJ03, lixisenatide, Lixisenatide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C02KX04, macitentan, Macitentan may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AX26, vortioxetine, Vortioxetine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J05AP08, sofosbuvir, Sofosbuvir may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01CA27, droxidopa, Droxidopa may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05CH03, tasimelteon, Tasimelteon may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L04AA32, apremilast, Apremilast may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L02BG02, formestane, Formestane may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V03AB34, fomepizole, Fomepizole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Neomycin is combined with Acenocoumarol.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, The risk or severity of nephrotoxicity can be increased when Dihydrostreptomycin is combined with Neomycin.]
[N05AA04, acepromazine, Neomycin may increase the neurotoxic activities of Acepromazine.]
[V04CX03, methacholine, The therapeutic efficacy of Methacholine can be decreased when used in combination with Neomycin.]
[S03AA06, gentamicin, The risk or severity of nephrotoxicity can be increased when Gentamicin is combined with Neomycin.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Neomycin is combined with Dicoumarol.]
[B01AF03, edoxaban, Edoxaban may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Neomycin is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Neomycin.]
[N05AX16, brexpiprazole, Neomycin may increase the neurotoxic activities of Brexpiprazole.]
[N05AX15, cariprazine, Neomycin may increase the neurotoxic activities of Cariprazine.]
[A10BF01, acarbose, The metabolism of Acarbose can be decreased when combined with Neomycin.]
[M02AA25, aceclofenac, The risk or severity of nephrotoxicity can be increased when Aceclofenac is combined with Neomycin.]
[M01AB11, acemetacin, The risk or severity of nephrotoxicity can be increased when Acemetacin is combined with Neomycin.]
[N05AB07, acetophenazine, Neomycin may increase the neurotoxic activities of Acetophenazine.]
[V03AB37, idarucizumab, Idarucizumab may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The risk or severity of nephrotoxicity can be increased when Tenofovir alafenamide is combined with Neomycin.]
[L01XG03, ixazomib, Ixazomib may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M04AB05, lesinurad, Lesinurad may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AE16, alminoprofen, The risk or severity of nephrotoxicity can be increased when Alminoprofen is combined with Neomycin.]
[N03AX23, brivaracetam, Brivaracetam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05BA08, bromazepam, Bromazepam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Magnesium Aluminum Silicate.]
[N06AA19, amineptin, Neomycin may increase the neurotoxic activities of Amineptine.]
[N05AX17, pimavanserin, Neomycin may increase the neurotoxic activities of Pimavanserin.]
[M02AA09, bufexamac, The risk or severity of nephrotoxicity can be increased when Bufexamac is combined with Neomycin.]
[C03CA02, bumetanide, The risk or severity of nephrotoxicity can be increased when Bumetanide is combined with Neomycin.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Bupivacaine.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01XX27, arsenic trioxide, Arsenic trioxide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CE04, azidocillin, The serum concentration of Neomycin can be decreased when it is combined with Azidocillin.]
[J01CA06, bacampicillin, The serum concentration of Neomycin can be decreased when it is combined with Bacampicillin.]
[A07EC04, balsalazide, The risk or severity of nephrotoxicity can be increased when Balsalazide is combined with Neomycin.]
[A06AH05, naldemedine, Naldemedine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Deutetrabenazine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Oxybuprocaine.]
[P01CA02, benznidazole, Benznidazole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N07XX13, valbenazine, Valbenazine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N07AB02, bethanechol, The therapeutic efficacy of Bethanechol can be decreased when used in combination with Neomycin.]
[J01MA23, delafloxacin, Delafloxacin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01EB09, acetylcholine, The therapeutic efficacy of Acetylcholine can be decreased when used in combination with Neomycin.]
[L01BC06, capecitabine, Capecitabine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A02BX12, bismuth subnitrate, Neomycin may increase the neurotoxic activities of Bismuth subnitrate.]
[C07AB07, bisoprolol, Bisoprolol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01DC10, cefprozil, The risk or severity of nephrotoxicity can be increased when Cefprozil is combined with Neomycin.]
[N05AD06, bromperidol, Neomycin may increase the neurotoxic activities of Bromperidol.]
[R03BA02, budesonide, Budesonide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AB07, bumadizone, The risk or severity of nephrotoxicity can be increased when Bumadizone is combined with Neomycin.]
[N06AA15, butriptyline, Neomycin may increase the neurotoxic activities of Butriptyline.]
[C01AA02, acetyldigoxins, The serum concentration of Acetyldigoxin can be decreased when it is combined with Neomycin.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Capsaicin.]
[R06AX18, acrivastine, Acrivastine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01EB02, carbachol, The therapeutic efficacy of Carbamoylcholine can be decreased when used in combination with Neomycin.]
[L02BB05, apalutamide, Apalutamide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N03AF01, carbamazepine, Neomycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01CA03, carbenicillin, The serum concentration of Neomycin can be decreased when it is combined with Carbenicillin.]
[L04AA37, baricitinib, Baricitinib may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01DE01, cefepime, The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Neomycin.]
[J01DD10, cefetamet, The risk or severity of nephrotoxicity can be increased when Cefetamet is combined with Neomycin.]
[J01DD09, cefodizime, The risk or severity of nephrotoxicity can be increased when Cefodizime is combined with Neomycin.]
[J01DC11, ceforanide, The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Neomycin.]
[J01DD13, cefpodoxime, The risk or severity of nephrotoxicity can be increased when Cefpodoxime is combined with Neomycin.]
[J01DD14, ceftibuten, The risk or severity of nephrotoxicity can be increased when Ceftibuten is combined with Neomycin.]
[J01GB14, plazomicin, The risk or severity of nephrotoxicity can be increased when Plazomicin is combined with Neomycin.]
[A16AX14, migalastat, Migalastat may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N03AX17, stiripentol, Stiripentol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Chloroxylenol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AC05, lornoxicam, The risk or severity of nephrotoxicity can be increased when Lornoxicam is combined with Neomycin.]
[N07XX15, inotersen, The risk or severity of nephrotoxicity can be increased when Inotersen is combined with Neomycin.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A06AX05, prucalopride, Prucalopride may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC23, cilostazol, Cilostazol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06BA14, solriamfetol, Solriamfetol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01AA11, clomocycline, The risk or severity of neuromuscular blockade can be increased when Clomocycline is combined with Neomycin.]
[J01DC04, cefaclor, The risk or severity of nephrotoxicity can be increased when Cefaclor is combined with Neomycin.]
[J01DB05, cefadroxil, The risk or severity of nephrotoxicity can be increased when Cefadroxil is combined with Neomycin.]
[J01DC03, cefamandole, The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Neomycin.]
[J01DB07, cefatrizine, The risk or severity of nephrotoxicity can be increased when Cefatrizine is combined with Neomycin.]
[J01DB04, cefazolin, The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Neomycin.]
[J01CF03, methicillin, The serum concentration of Neomycin can be decreased when it is combined with Meticillin.]
[J01DC09, cefmetazole, The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Neomycin.]
[J01DC06, cefonicid, The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Neomycin.]
[J01DD12, cefoperazone, The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Neomycin.]
[J01DD01, cefotaxime, The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Neomycin.]
[J01DC05, cefotetan, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Neomycin.]
[N05AA06, cyamemazine, Neomycin may increase the neurotoxic activities of Cyamemazine.]
[J01DC07, cefotiam, The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Neomycin.]
[J01DC01, cefoxitin, The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Neomycin.]
[J01DD03, cefsulodin, The risk or severity of nephrotoxicity can be increased when Cefsulodin is combined with Neomycin.]
[J01DD02, ceftazidime, The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Neomycin.]
[J01DD07, ceftizoxime, The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Neomycin.]
[J01DD04, ceftriaxone, The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Neomycin.]
[S01AA27, cefuroxime, The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Neomycin.]
[M03BX08, cyclobenzaprine, Cyclobenzaprine may increase the neurotoxic activities of Neomycin.]
[N07XX11, pitolisant, Pitolisant may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01DB01, cephalexin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Neomycin.]
[J01DB02, cephaloridine, The risk or severity of nephrotoxicity can be increased when Cefaloridine is combined with Neomycin.]
[J01DB03, cephalothin, The risk or severity of nephrotoxicity can be increased when Cefalotin is combined with Neomycin.]
[J01DB08, cephapirin, The risk or severity of nephrotoxicity can be increased when Cefapirin is combined with Neomycin.]
[J01DB09, cephradine, The risk or severity of nephrotoxicity can be increased when Cefradine is combined with Neomycin.]
[A16AX16, givosiran, The risk or severity of nephrotoxicity can be increased when Givosiran is combined with Neomycin.]
[M09AX08, golodirsen, Golodirsen may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01XA12, dexpanthenol, Dexpanthenol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L04AA53, teprotumumab, The risk or severity of ototoxicity can be increased when Teprotumumab is combined with Neomycin.]
[R02AA03, dichlorobenzyl alcohol, Dichlorobenzyl alcohol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G03DB08, dienogest, Dienogest may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AH02, rofecoxib, The risk or severity of nephrotoxicity can be increased when Rofecoxib is combined with Neomycin.]
[C08CA16, clevidipine, Clevidipine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AC04, droxicam, The risk or severity of nephrotoxicity can be increased when Droxicam is combined with Neomycin.]
[V08CA05, mangafodipir, Mangafodipir may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M02AA27, dexketoprofen, The risk or severity of nephrotoxicity can be increased when Dexketoprofen is combined with Neomycin.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Dyclonine.]
[P01BA01, chloroquine, Chloroquine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AF03, chlorprothixene, Neomycin may increase the neurotoxic activities of Chlorprothixene.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N02BA07, ethenzamide, The risk or severity of nephrotoxicity can be increased when Ethenzamide is combined with Neomycin.]
[N02BA03, choline salicylate, Choline salicylate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AB08, etodolac, The risk or severity of nephrotoxicity can be increased when Etodolac is combined with Neomycin.]
[M02AA06, etofenamate, The risk or severity of nephrotoxicity can be increased when Etofenamate is combined with Neomycin.]
[M01AX25, chondroitin sulfates, Chondroitin sulfate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01FX21, naxitamab, Neomycin may increase the neurotoxic activities of Naxitamab.]
[M01AE05, fenbufen, The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Neomycin.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N02BG07, flupirtine, Flupirtine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A02BA01, cimetidine, Cimetidine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S03AA07, ciprofloxacin, Ciprofloxacin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01XA01, cisplatin, The risk or severity of nephrotoxicity can be increased when Cisplatin is combined with Neomycin.]
[V09AB03, ioflupane I-123, Ioflupane I-123 may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Technetium Tc-99m exametazime may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Florbetaben (18F) may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AG01, mefenamic acid, The risk or severity of nephrotoxicity can be increased when Mefenamic acid is combined with Neomycin.]
[J01FF01, clindamycin, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Clindamycin.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Levobupivacaine.]
[N06AA04, clomipramine, Clomipramine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N03AE01, clonazepam, Clonazepam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AH06, clothiapine, Neomycin may increase the neurotoxic activities of Clothiapine.]
[M02AA08, felbinac, The risk or severity of nephrotoxicity can be increased when Felbinac is combined with Neomycin.]
[J01CF02, cloxacillin, The serum concentration of Neomycin can be decreased when it is combined with Cloxacillin.]
[N05AH02, clozapine, Clozapine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01GB12, arbekacin, The risk or severity of nephrotoxicity can be increased when Arbekacin is combined with Neomycin.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Cocaine.]
[M01AX13, proquazone, The risk or severity of nephrotoxicity can be increased when Proquazone is combined with Neomycin.]
[J01CA18, hetacillin, The serum concentration of Neomycin can be decreased when it is combined with Hetacillin.]
[M04AC01, colchicine, Colchicine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01XB01, colistin, The risk or severity of nephrotoxicity can be increased when Colistin is combined with Neomycin.]
[J01DE02, cefpirome, The risk or severity of nephrotoxicity can be increased when Cefpirome is combined with Neomycin.]
[A04AA03, tropisetron, Tropisetron may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of nephrotoxicity can be increased when Imidazole salicylate is combined with Neomycin.]
[B01AC10, indobufen, The risk or severity of nephrotoxicity can be increased when Indobufen is combined with Neomycin.]
[J05AB14, valganciclovir, Valganciclovir may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C05BB03, invert sugar, Invert sugar may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V08AB09, iodixanol, Iodixanol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V08AB05, iopromide, Iopromide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V08AB07, ioversol, Ioversol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V08AB12, ioxilan, Ioxilan may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Neomycin.]
[C01AA06, lanatoside C, The risk or severity of adverse effects can be increased when Neomycin is combined with Lanatoside C.]
[N02CC05, almotriptan, Almotriptan may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AH04, parecoxib, The risk or severity of nephrotoxicity can be increased when Parecoxib is combined with Neomycin.]
[B01AB12, bemiparin, The therapeutic efficacy of Neomycin can be decreased when used in combination with Bemiparin.]
[S01AD03, acyclovir, The risk or severity of nephrotoxicity can be increased when Acyclovir is combined with Neomycin.]
[N05BA10, ketazolam, Ketazolam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AA06, kebuzone, The risk or severity of nephrotoxicity can be increased when Kebuzone is combined with Neomycin.]
[N03AX09, lamotrigine, Lamotrigine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N07BC04, lofexidine, Lofexidine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AB09, lonazolac, The risk or severity of nephrotoxicity can be increased when Lonazolac is combined with Neomycin.]
[M02AA31, loxoprofen, The risk or severity of nephrotoxicity can be increased when Loxoprofen is combined with Neomycin.]
[J01DC08, loracarbef, The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Neomycin.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Magnesium carbonate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B05XA10, magnesium phosphate, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Magnesium phosphate.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CA14, methampicillin, The serum concentration of Neomycin can be decreased when it is combined with Metampicillin.]
[N05AD03, metylperon, Melperone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J05AF07, tenofovir disoproxil, The risk or severity of nephrotoxicity can be increased when Tenofovir disoproxil is combined with Neomycin.]
[L01AA01, cyclophosphamide, Cyclophosphamide may increase the neurotoxic activities of Neomycin.]
[J04AB01, cycloserine, Cycloserine may increase the neurotoxic activities of Neomycin.]
[S01XA18, cyclosporine, The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Neomycin.]
[M02AA02, mofebutazone, The risk or severity of nephrotoxicity can be increased when Mofebutazone is combined with Neomycin.]
[M01AX22, morniflumate, The risk or severity of nephrotoxicity can be increased when Morniflumate is combined with Neomycin.]
[M01AH05, etoricoxib, The risk or severity of nephrotoxicity can be increased when Etoricoxib is combined with Neomycin.]
[L01AX04, dacarbazine, Dacarbazine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M03CA01, dantrolene, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Dantrolene.]
[M01AX01, nabumetone, The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Neomycin.]
[N07BB05, nalmefene, Nalmefene may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01AA01, demeclocycline, The risk or severity of neuromuscular blockade can be increased when Demeclocycline is combined with Neomycin.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AX06, nefazodone, Nefazodone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01DX16, nicorandil, Nicorandil may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M03AC11, cisatracurium, Neomycin may increase the neuromuscular blocking activities of Cisatracurium.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A07EC03, olsalazine, The risk or severity of nephrotoxicity can be increased when Olsalazine is combined with Neomycin.]
[N06AA01, desipramine, Desipramine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01AA07, deslanoside, The risk or severity of adverse effects can be increased when Neomycin is combined with Deslanoside.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V04CH02, indigo carmine, Indigotindisulfonic acid may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AE12, oxaprozin, The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Neomycin.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[P03AC04, permethrin, Permethrin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05BA01, diazepam, Diazepam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CE05, phenethicillin, The serum concentration of Neomycin can be decreased when it is combined with Pheneticillin.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Phenol.]
[N06AA08, dibenzepin, Neomycin may increase the neurotoxic activities of Dibenzepin.]
[R05DA08, pholcodine, Pholcodine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M05BA02, clodronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Neomycin is combined with Clodronic acid.]
[S01BC03, diclofenac, The risk or severity of nephrotoxicity can be increased when Diclofenac is combined with Neomycin.]
[J01CF01, dicloxacillin, The serum concentration of Neomycin can be decreased when it is combined with Dicloxacillin.]
[J05AD01, foscarnet, The risk or severity of nephrotoxicity can be increased when Foscarnet is combined with Neomycin.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AD05, pipamperone, Neomycin may increase the neurotoxic activities of Pipamperone.]
[C03CA03, piretanide, The serum concentration of Neomycin can be increased when it is combined with Piretanide.]
[C08CA03, isradipine, Isradipine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[D07XC04, diflucortolone, Difluocortolone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N02BA11, diflunisal, The risk or severity of nephrotoxicity can be increased when Diflunisal is combined with Neomycin.]
[C01AA04, digitoxin, The risk or severity of adverse effects can be increased when Neomycin is combined with Digitoxin.]
[C01AA05, digoxin, The serum concentration of Digoxin can be decreased when it is combined with Neomycin.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J05AE08, atazanavir, The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Neomycin.]
[H03BC01, potassium perchlorate, Potassium perchlorate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Pramocaine.]
[V03AB09, dimercaprol, Dimercaprol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Dimethyl sulfoxide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CE03, propicillin, The serum concentration of Neomycin can be decreased when it is combined with Propicillin.]
[N02BB04, propyphenazone, The risk or severity of nephrotoxicity can be increased when Propyphenazone is combined with Neomycin.]
[M01AB14, proglumetacin, The risk or severity of nephrotoxicity can be increased when Proglumetacin is combined with Neomycin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Diphenhydramine.]
[N06AA23, quinupramine, Neomycin may increase the neurotoxic activities of Quinupramine.]
[N05AL04, remoxipride, Remoxipride may increase the neurotoxic activities of Neomycin.]
[S01AX06, resorcinol, Resorcinol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AX08, risperidone, Risperidone may increase the neurotoxic activities of Neomycin.]
[R06AE09, levocetirizine, Levocetirizine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Ropivacaine.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01BC05, ketorolac, The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Neomycin.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N02BA06, salsalate, The risk or severity of nephrotoxicity can be increased when Salsalate is combined with Neomycin.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AA16, dothiepin, Neomycin may increase the neurotoxic activities of Dosulepin.]
[N06AA12, doxepin, Doxepin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AD08, droperidol, Droperidol may increase the neurotoxic activities of Neomycin.]
[A08AA10, sibutramine, Sibutramine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A12CA02, sodium sulfate, Sodium sulfate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AL02, sultopride, Neomycin may increase the neurotoxic activities of Sultopride.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CG02, tazobactam, The therapeutic efficacy of Neomycin can be decreased when used in combination with Tazobactam.]
[J01CA17, temocillin, The serum concentration of Neomycin can be decreased when it is combined with Temocillin.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AC02, tenoxicam, The risk or severity of nephrotoxicity can be increased when Tenoxicam is combined with Neomycin.]
[N05AB05, thiopropazate, Neomycin may increase the neurotoxic activities of Thiopropazate.]
[N06AX14, tianeptine, Neomycin may increase the neurotoxic activities of Tianeptine.]
[M01AG02, tolfenamic acid, The risk or severity of nephrotoxicity can be increased when Tolfenamic acid is combined with Neomycin.]
[N06AG03, toloxatone, Toloxatone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C03CA04, torsemide, The risk or severity of ototoxicity can be increased when Torasemide is combined with Neomycin.]
[J01AA12, tigecycline, The risk or severity of neuromuscular blockade can be increased when Tigecycline is combined with Neomycin.]
[N05CC01, chloral hydrate, Chloral hydrate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AL06, veralipride, Neomycin may increase the neurotoxic activities of Veralipride.]
[L01CA04, vinorelbine, Vinorelbine may increase the neurotoxic activities of Neomycin.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AB04, zomepirac, The risk or severity of nephrotoxicity can be increased when Zomepirac is combined with Neomycin.]
[N03AX15, zonisamide, Zonisamide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AX11, zotepine, Neomycin may increase the neurotoxic activities of Zotepine.]
[L01XA02, carboplatin, The risk or severity of nephrotoxicity can be increased when Carboplatin is combined with Neomycin.]
[C02AC02, guanfacine, Guanfacine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01BG01, moricizine, Moricizine may increase the neurotoxic activities of Neomycin.]
[L03AX05, pidotimod, Pidotimod may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05CD04, estazolam, Estazolam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Neomycin.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Etidocaine.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AE03, sertindole, Neomycin may increase the neurotoxic activities of Sertindole.]
[L04AD02, tacrolimus, The risk or severity of nephrotoxicity can be increased when Tacrolimus is combined with Neomycin.]
[P01AX07, trimetrexate, Trimetrexate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AX12, bupropion, Bupropion may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Sodium aurothiomalate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B05AA05, dextran, Dextran may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M05BA01, etidronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Neomycin is combined with Etidronic acid.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AE04, fenoprofen, The risk or severity of nephrotoxicity can be increased when Fenoprofen is combined with Neomycin.]
[N02AB03, fentanyl, Fentanyl may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01BB06, clofarabine, Clofarabine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G04BD02, flavoxate, Flavoxate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N02BG04, floctafenine, The risk or severity of nephrotoxicity can be increased when Floctafenine is combined with Neomycin.]
[J01CF05, floxacillin, The serum concentration of Neomycin can be decreased when it is combined with Flucloxacillin.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J02AX01, flucytosine, Flucytosine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V03AB25, flumazenil, Flumazenil may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AA14, melitracen, Neomycin may increase the neurotoxic activities of Melitracen.]
[V03AZ01, ethanol, Ethanol may increase the neurotoxic activities of Neomycin.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01BC02, fluorouracil, Neomycin can cause a decrease in the absorption of Fluorouracil resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AF01, flupenthixol, Flupentixol may increase the neurotoxic activities of Neomycin.]
[N05AB02, fluphenazine, Fluphenazine may increase the neurotoxic activities of Neomycin.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01BC04, flurbiprofen, The risk or severity of nephrotoxicity can be increased when Flurbiprofen is combined with Neomycin.]
[N05AG01, fluspirilene, Neomycin may increase the neurotoxic activities of Fluspirilene.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01AA07, framycetin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Neomycin.]
[L01BC03, tegafur, Tegafur may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M03AA01, alcuronium, The therapeutic efficacy of Alcuronium can be increased when used in combination with Neomycin.]
[C03CA01, furosemide, Furosemide may increase the ototoxic activities of Neomycin.]
[M05BA04, alendronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Neomycin is combined with Alendronic acid.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AL05, amisulpride, Neomycin may increase the neurotoxic activities of Amisulpride.]
[M03AC02, gallamine, The therapeutic efficacy of Gallamine can be increased when used in combination with Neomycin.]
[S01AD09, ganciclovir, Ganciclovir may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C10AB04, gemfibrozil, Gemfibrozil may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01XA03, telavancin, Telavancin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A10BB07, glipizide, Glipizide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01EX02, sorafenib, The serum concentration of Sorafenib can be decreased when it is combined with Neomycin.]
[M01CB04, aurothioglucose, Aurothioglucose may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01LA03, pegaptanib, Pegaptanib may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Neomycin is combined with Fluindione.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01EX01, guanethidine, Guanethidine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AD01, haloperidol, Haloperidol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AH04, quetiapine, Quetiapine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06BX13, idebenone, Idebenone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01XA14, heparin, The therapeutic efficacy of Neomycin can be decreased when used in combination with Heparin.]
[B05CB03, magnesium citrate, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Magnesium citrate.]
[A12CC03, magnesium gluconate, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Magnesium gluconate.]
[G03DC01, allylestrenol, Allylestrenol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A07EC02, mesalamine, The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Neomycin.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M02AA26, nimesulide, The risk or severity of nephrotoxicity can be increased when Nimesulide is combined with Neomycin.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C02DB02, hydralazine, Hydralazine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Neomycin.]
[B05XA17, potassium acetate, Potassium acetate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G04BD06, propiverine, Propiverine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AX07, prothipendyl, Neomycin may increase the neurotoxic activities of Prothipendyl.]
[B05AA07, hetastarch, Hydroxyethyl Starch may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M05BA07, risedronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Neomycin is combined with Risedronic acid.]
[R02AX02, ibuprofen, The risk or severity of nephrotoxicity can be increased when Ibuprofen is combined with Neomycin.]
[B05XA08, sodium acetate, Sodium acetate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B05CB02, sodium citrate, Neomycin may increase the neurotoxic activities of Sodium citrate.]
[L01AA06, ifosfamide, Ifosfamide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AA02, imipramine, Imipramine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01CD01, paclitaxel, Neomycin may increase the neurotoxic activities of Paclitaxel.]
[R01AD07, tixocortol, Tixocortol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01CE01, topotecan, Topotecan may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01BC01, indomethacin, The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Neomycin.]
[A11HA07, inositol, Inositol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AX17, milnacipran, Milnacipran may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[R01AA02, cyclopentamine, The risk or severity of adverse effects can be increased when Neomycin is combined with Cyclopentamine.]
[S01XA28, varenicline, Varenicline may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Articaine.]
[A10BH01, sitagliptin, Sitagliptin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05CH02, ramelteon, Ramelteon may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V03AB01, ipecac, Ipecac may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J05AF04, stavudine, Stavudine may increase the neurotoxic activities of Neomycin.]
[N06AA13, iprindole, Neomycin may increase the neurotoxic activities of Iprindole.]
[N05AA07, chlorproethazine, Neomycin may increase the neurotoxic activities of Chlorproethazine.]
[J04AC01, isoniazid, Isoniazid may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J05AX05, inosine pranobex, Inosine pranobex may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[D10BA01, isotretinoin, Isotretinoin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01AA24, kanamycin, The risk or severity of nephrotoxicity can be increased when Kanamycin is combined with Neomycin.]
[N01AX03, ketamine, Ketamine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC22, prasugrel, Prasugrel may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M02AA10, ketoprofen, The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Neomycin.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, The risk or severity of nephrotoxicity can be increased when Tiaprofenic acid is combined with Neomycin.]
[C07AG01, labetalol, Labetalol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N04BB01, amantadine, Amantadine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Neomycin.]
[A06AX03, lubiprostone, Lubiprostone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C03CC01, ethacrynic acid, The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Neomycin.]
[J01CA11, amdinocillin, The serum concentration of Neomycin can be decreased when it is combined with Amdinocillin.]
[J01CA08, amdinocillin pivoxil, The serum concentration of Neomycin can be decreased when it is combined with Pivmecillinam.]
[J01FF02, lincomycin, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Lincomycin.]
[S01AA21, amikacin, The risk or severity of nephrotoxicity can be increased when Amikacin is combined with Neomycin.]
[N06AA07, lofepramine, Neomycin may increase the neurotoxic activities of Lofepramine.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AH01, loxapine, Loxapine may increase the neurotoxic activities of Neomycin.]
[J01AA04, lymecycline, The risk or severity of neuromuscular blockade can be increased when Lymecycline is combined with Neomycin.]
[B05XA11, magnesium chloride, Magnesium chloride may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Magnesium hydroxide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A12CC10, magnesium oxide, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Magnesium oxide.]
[V04CC02, magnesium sulfate, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Neomycin.]
[L01BA05, pralatrexate, Pralatrexate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V04CX04, mannitol, The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Neomycin.]
[N06AA21, maprotiline, Maprotiline may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M02AA18, meclofenamic acid, The risk or severity of nephrotoxicity can be increased when Meclofenamic acid is combined with Neomycin.]
[C01AA08, medigoxin, The serum concentration of Metildigoxin can be decreased when it is combined with Neomycin.]
[B01AB06, nadroparin, The therapeutic efficacy of Neomycin can be decreased when used in combination with Nadroparin.]
[B01AB05, enoxaparin, The therapeutic efficacy of Neomycin can be decreased when used in combination with Enoxaparin.]
[B01AB04, dalteparin, The therapeutic efficacy of Neomycin can be decreased when used in combination with Dalteparin.]
[N06DX01, memantine, Memantine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Mepivacaine.]
[G04BX16, tiopronin, Tiopronin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AC03, mesoridazine, Mesoridazine may increase the neurotoxic activities of Neomycin.]
[N05AX13, paliperidone, Paliperidone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01AA05, methacycline, The risk or severity of neuromuscular blockade can be increased when Metacycline is combined with Neomycin.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06BA03, methamphetamine, Metamfetamine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[H03BB02, methimazole, Methimazole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01BA04, pemetrexed, Neomycin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L04AX03, methotrexate, The serum concentration of Methotrexate can be decreased when it is combined with Neomycin.]
[N05AA02, methotrimeprazine, Neomycin may increase the neurotoxic activities of Methotrimeprazine.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C02AB01, methyldopa, Methyldopa may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V04CG05, methylene blue, Methylene blue may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G03EK01, methyltestosterone, Methyltestosterone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A03FA01, metoclopramide, Metoclopramide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C03BA08, metolazone, Metolazone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C07AB02, metoprolol, Metoprolol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V04CD01, metyrapone, Metyrapone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CA10, mezlocillin, The serum concentration of Neomycin can be decreased when it is combined with Mezlocillin.]
[N02BB03, aminopyrine, The risk or severity of nephrotoxicity can be increased when Aminophenazone is combined with Neomycin.]
[B01AB07, parnaparin, The therapeutic efficacy of Neomycin can be decreased when used in combination with Parnaparin.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AB10, tinzaparin, The therapeutic efficacy of Neomycin can be decreased when used in combination with Tinzaparin.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01AA08, minocycline, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Minocycline.]
[N05AE02, molindone, Neomycin may increase the neurotoxic activities of Molindone.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AA09, amitriptyline, Amitriptyline may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01DD06, moxalactam, The risk or severity of nephrotoxicity can be increased when Latamoxef is combined with Neomycin.]
[L04AB05, certolizumab pegol, Certolizumab pegol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G04BA01, ammonium chloride, Ammonium chloride may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L04AA06, mycophenolic acid, Mycophenolic acid may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M03AC03, vecuronium, The therapeutic efficacy of Vecuronium can be increased when used in combination with Neomycin.]
[N06AA17, amoxapine, Amoxapine may increase the neurotoxic activities of Neomycin.]
[C07AA12, nadolol, Nadolol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CA04, amoxicillin, Amoxicillin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CF06, nafcillin, The serum concentration of Neomycin can be decreased when it is combined with Nafcillin.]
[V03AB15, naloxone, Naloxone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M02AA12, naproxen, The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Neomycin.]
[N06AX21, duloxetine, Duloxetine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Pentaerythritol tetranitrate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AX14, iloperidone, Neomycin may increase the neurotoxic activities of Iloperidone.]
[J02AA01, amphotericin B, The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Neomycin.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L03AX16, plerixafor, Plerixafor may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01AA23, netilmicin, The risk or severity of nephrotoxicity can be increased when Netilmicin is combined with Neomycin.]
[N06AX23, desvenlafaxine, Desvenlafaxine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J05AB11, valacyclovir, The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Neomycin.]
[C01CE01, inamrinone, Amrinone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Neomycin is combined with Nicotine.]
[C08CA05, nifedipine, Nifedipine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M02AA17, niflumic acid, The risk or severity of nephrotoxicity can be increased when Niflumic acid is combined with Neomycin.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AA10, nortriptyline, Nortriptyline may increase the neurotoxic activities of Neomycin.]
[B01AB08, reviparin, The therapeutic efficacy of Neomycin can be decreased when used in combination with Reviparin.]
[N06AA05, opipramol, Neomycin may increase the neurotoxic activities of Opipramol.]
[N02AA02, opium, Opium may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01AC01, ouabain, The risk or severity of adverse effects can be increased when Neomycin is combined with Ouabain.]
[M05BA08, zoledronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Neomycin is combined with Zoledronic acid.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AE01, oxypertine, Neomycin may increase the neurotoxic activities of Oxypertine.]
[S01BC02, oxyphenbutazone, The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Neomycin.]
[S01AA04, oxytetracycline, The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Neomycin.]
[N05AH05, asenapine, Neomycin may increase the neurotoxic activities of Asenapine.]
[B01AB09, danaparoid, The therapeutic efficacy of Neomycin can be decreased when used in combination with Danaparoid.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be increased when used in combination with Neomycin.]
[J04AB30, capreomycin, The risk or severity of nephrotoxicity can be increased when Capreomycin is combined with Neomycin.]
[A07AA06, paromomycin, The risk or severity of nephrotoxicity can be increased when Paromomycin is combined with Neomycin.]
[G04BD11, fesoterodine, Fesoterodine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C07AA23, penbutolol, Penbutolol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AG03, penfluridol, Neomycin may increase the neurotoxic activities of Penfluridol.]
[S01AA14, penicillin G, The serum concentration of Neomycin can be decreased when it is combined with Benzylpenicillin.]
[J01CE09, penicillin G procaine, Procaine benzylpenicillin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CE02, penicillin V, Neomycin can cause a decrease in the absorption of Phenoxymethylpenicillin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05CA01, pentobarbital, Pentobarbital may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[L01XX08, pentostatin, Neomycin may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AB10, perazine, Neomycin may increase the neurotoxic activities of Perazine.]
[N05AB03, perphenazine, Perphenazine may increase the neurotoxic activities of Neomycin.]
[G04BX06, phenazopyridine, The risk or severity of nephrotoxicity can be increased when Phenazopyridine is combined with Neomycin.]
[N06AF03, phenelzine, Phenelzine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Neomycin is combined with Phenindione.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Neomycin is combined with Phenprocoumon.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M02AA01, phenylbutazone, The risk or severity of nephrotoxicity can be increased when Phenylbutazone is combined with Neomycin.]
[S01AE05, levofloxacin, Levofloxacin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J05AB12, cidofovir, The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Neomycin.]
[S01EB01, pilocarpine, The therapeutic efficacy of Pilocarpine can be decreased when used in combination with Neomycin.]
[N05AG02, pimozide, Neomycin may increase the neurotoxic activities of Pimozide.]
[C07AA03, pindolol, Pindolol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AC04, pipothiazine, Neomycin may increase the neurotoxic activities of Pipotiazine.]
[N06BX03, piracetam, Piracetam may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[S01BC06, piroxicam, The risk or severity of nephrotoxicity can be increased when Piroxicam is combined with Neomycin.]
[J01DD16, cefditoren, The risk or severity of nephrotoxicity can be increased when Cefditoren is combined with Neomycin.]
[J01CA02, pivampicillin, The serum concentration of Neomycin can be decreased when it is combined with Pivampicillin.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A10BH03, saxagliptin, Saxagliptin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[M02AA16, feprazone, The risk or severity of nephrotoxicity can be increased when Feprazone is combined with Neomycin.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Prilocaine.]
[M04AB01, probenecid, Probenecid may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01BA02, procainamide, Neomycin may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Procaine.]
[C10AB05, fenofibrate, Fenofibrate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AB04, prochlorperazine, Prochlorperazine may increase the neurotoxic activities of Neomycin.]
[N05AA03, promazine, Promazine may increase the neurotoxic activities of Neomycin.]
[R06AD02, promethazine, Promethazine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N05AC01, periciazine, Neomycin may increase the neurotoxic activities of Periciazine.]
[C07AA05, propranolol, Propranolol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01AB01, proscillaridin, The risk or severity of adverse effects can be increased when Neomycin is combined with Proscillaridin.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC09, epoprostenol, Epoprostenol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N06AA11, protriptyline, Protriptyline may increase the neurotoxic activities of Neomycin.]
[N05AX12, aripiprazole, Neomycin may increase the neurotoxic activities of Aripiprazole.]
[N07XX07, dalfampridine, Dalfampridine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[P02CC01, pyrantel, The therapeutic efficacy of Pyrantel can be increased when used in combination with Neomycin.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01BA01, quinidine, Neomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Neomycin.]
[A02BA02, ranitidine, Ranitidine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01AA09, rolitetracycline, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Rolitetracycline.]
[N02BA05, salicylamide, The risk or severity of nephrotoxicity can be increased when Salicylamide is combined with Neomycin.]
[A07EC01, sulfasalazine, The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Neomycin.]
[S01BC08, salicylic acid, The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Neomycin.]
[N05CA06, secobarbital, Secobarbital may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[J01GB08, sisomicin, The risk or severity of nephrotoxicity can be increased when Sisomicin is combined with Neomycin.]
[A12CD01, sodium fluoride, Sodium fluoride may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[V04CC01, sorbitol, Sorbitol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
